Your cart is currently empty!
α-Blockers are a class of drugs that inhibit alpha-adrenergic receptors, affecting vascular tone, smooth muscle contraction, and neurotransmitter release. Their applications range from treating hypertension to managing specific conditions like pheochromocytoma and benign prostatic hyperplasia (BPH).
Type | Drugs | Mechanism | Applications | Adverse Effects |
---|---|---|---|---|
Nonselective | Phenoxybenzamine | Irreversible α1 and α2 | Pheochromocytoma (preoperative to prevent catecholamine crisis) | Orthostatic hypotension, reflex tachycardia |
Phentolamine | Reversible α1 and α2 | MAO inhibitor-associated hypertensive crisis; cocaine-induced hypertension (2nd line) | Same as phenoxybenzamine | |
α1-selective | Prazosin, Terazosin, | Block α1 receptors | BPH (urinary symptoms); PTSD (prazosin); hypertension (except tamsulosin) | First-dose orthostatic hypotension, dizziness, headache |
Doxazosin, Tamsulosin | ||||
α2-selective | Mirtazapine | Block α2 receptors | Depression | Sedation, increased appetite, increased serum cholesterol |
Condition | Heart Rate | Blood Pressure | Explanation |
---|---|---|---|
Before α-blockade | Reflex bradycardia | Increased (MAP, systolic) | α1-mediated vasoconstriction |
After α-blockade | Reflex tachycardia | Decreased (MAP, diastolic) | Unopposed β2-mediated vasodilation |
Drug | Response Before α-Blockade | Response After α-Blockade | Key Feature |
---|---|---|---|
Epinephrine | Increased MAP (α1 > β2) | Decreased MAP (β2 > α1) | Exhibits “reversal” with blockade |
Phenylephrine | Increased MAP (pure α1) | Suppressed response | No reversal as it lacks β activity |